HR Execs on the Move

Apollo Informations Services Inc

www.aisi-med.com

 
Apollo Informations Services Inc is a Fort Myers, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Medivators

Medivators, a wholly owned subsidiary of Cantel Medical Corp. (NYSE:CMN), is a leading provider of infection control products and services that ensure the safe and proper disinfection of endoscopes and other devices. Beyond the full line of Medivators medical device reprocessing systems, disinfectants, detergents and other supplies for endoscopy, Medivators also provides sterilants, dialysate concentrates and other supplies for renal dialysis, hollow fiber membrane filtration and separation technologies for medical and non medical applications and liquid chemical germicides and decontamination products and services used in other applications for infection prevention and control. Medivators new low-temperature sterilization service provides superior material compatibility over legacy sterilization methods. Medivators was founded in 1974 and publicly held since 1983 and employs approximately 400 people.

Motion Picture and Television Fund

MPTF is unique as a national model of integrated health and human services and that there is no other such organization dedicated to taking care of a single industry. MPTF has six health centers located in Southern California.

Creating Wellness

Creating Wellness is a Mahwah, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III

Peninsula Open Space Trust

Enjoy and support protected local lands, where people and nature connect and thrive. Join POST for a hike, film screening or other event—or become a donor!